FOR IMMEDIATE RELEASE
A Leeds-based businesswoman has developed a line of revolutionary products set to improve the falling cervical screening rate in the UK.
On 17th October, medical underwear supplier Dignity Wear, will launch a range of women’s briefs specifically designed for maximum privacy during cervical screening tests in a bid to encourage more women to attend the potentially life-saving tests.
According to government statistics, more than one million women aged 25 – 64 years, did not attend their cervical screening test in 2016. Screening attendance has dramatically fallen over the last 10 years and is now at a 19-year low.
Founded in 2015 by former clinical Hypnotherapist Sally Benson, Dignity Wear was established with the aim of empowering patients and reducing feelings of vulnerability when attending intimate medical examinations.
Dignity Wear products will limit unnecessary exposure and help women to retain their modesty whist attending their smear test.
Having carried out an independent survey of more than 200 women, Sally identified that 66% of women are more likely to attend a smear test if they have access to under garments which provide privacy during the examination.
Dignity Wear’s cancer combatting underwear will feature a discreet opening, allowing medical professionals to carry out a smear test with minimal patient exposure.
Commenting on the launch of Dignity Wear, founder Sally Benson said:
“In recent years, cervical cancer has become the most common cancer among women under the age of 35. Most patients understand that going to a physician involves a physical examination that may require removal of some or all of their clothing and being undressed in front of a stranger. A rising number of patients are particularly uncomfortable with this and as a result are not attending their necessary medical screenings and check-ups.
“Following my own unpleasant experience at a smear test, I felt the real need to create something for patients that will protect their lack of dignity and increase levels of privacy.
“Each year, 3200 women are diagnosed as having cervical cancer at any stage. As well as the clear health benefit to patients, increasing the amount of smear test attendees will provide less strain on the NHS as the average cost per individual diagnosed with cervical cancer is £19,261.
“I am thrilled to be launching Dignity Wear products; it has been a long and exciting journey and it will be fantastic to see my vision come to life. If my products encourage even one woman to attend her examination to prevent this terrible disease, I will have succeeded.”
Dignity Wear also has plans to launch other products including a men’s range later this year.
Dignity Wear is a form of medical underwear which can be worn by intimate test attendees to reduce exposure and feelings of vulnerability. Essentially, the attendee can keep their underwear on whilst undergoing the examination.
Dignity Wear Ltd, founded by former clinical hypnotherapist, Sally Benson, was originally established as personal experience demonstrated that there was often a gross lack of privacy during routine gynaecological procedures. Sally’s extensive research with health practitioners and an independent survey of over 200 women highlighted this problem.
Sally began to explore this issue in areas such as PAP/smear tests, cell removal and other routine exploratory tests and discovered that a large proportion of women all over the world are generally unhappy with the unnecessary exposure they are subjected to.
This research also highlighted that due to this exposure, many women are not attending routine preventative tests. In the UK alone, 37% of young women aged between 25-29 are not attending their smear/PAP tests. This is having a great impact on the rates of early detection cervical which often leads to premature death.
Dignity Wear aims to empower men and women to expect maximum privacy and respect during routine investigations through the use of their products, no matter what cultural, religious or generational background.
The company goal is to transform the Global patient experience through education, working with healthcare partners from around the world.
Copyright © 2019 JournoLink Ltd. All Rights Reserved
JournoLink Ltd is registered in England and Wales, No. 08783164. Registered Office: 9-11 Castle St, Cardiff CF10 1BS